Radiopharmaceuticals Market Is Projected to Grow at a High CAGR of 18.3 % to Comprise Worth US $12.2 Bn by the End of 2018
Due to the highly fragmented nature of the market for radiopharmaceuticals, the leading global healthcare companies are focused on offering a wide range of diagnostic and therapeutic radiopharmaceuticals to boost their earnings, reports Transparency Market Research (TMR) in a new study. The leading companies in the global radiopharmaceuticals market are Covidien, followed by Lantheus Medical Imaging, IBA Group, and Positron Corporation. They held approximately19.4% of the total market revenue as of 2011.
View full press release